UBXN2B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.316000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.380200E-01
Normal-vs-Stage2
3.865400E-01
Normal-vs-Stage3
1.124450E-02
Normal-vs-Stage4
9.713800E-01
Stage1-vs-Stage2
6.843400E-01
Stage1-vs-Stage3
6.214200E-02
Stage1-vs-Stage4
3.315600E-01
Stage2-vs-Stage3
2.233700E-04
Stage2-vs-Stage4
2.939600E-01
Stage3-vs-Stage4
6.917800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.049800E-01
Normal-vs-AfricanAmerican
8.854600E-01
Normal-vs-Asian
1.835400E-01
Caucasian-vs-AfricanAmerican
8.358300E-02
Caucasian-vs-Asian
3.111800E-01
AfricanAmerican-vs-Asian
9.975500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.874600E-01
Normal-vs-Female
2.769000E-01
Male-vs-Female
7.289000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.737400E-01
Normal-vs-Age(41-60Yrs)
6.608200E-01
Normal-vs-Age(61-80Yrs)
2.241200E-01
Normal-vs-Age(81-100Yrs)
1.710390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.037600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.299800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.014800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.385980E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.597610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.932200E-02
Normal-vs-Daily Drinker
4.338400E-01
Normal-vs-Weekly Drinker
2.511400E-01
Normal-vs-Occasional Drinker
5.421600E-01
Normal-vs-Social Drinker
3.281200E-01
Non Drinker-vs-Daily Drinker
5.064600E-01
Non Drinker-vs-Weekly Drinker
6.350400E-01
Non Drinker-vs-Occasional Drinker
8.297700E-02
Non Drinker-vs-Social Drinker
1.732840E-01
Daily Drinker-vs-Weekly Drinker
8.407400E-01
Daily Drinker-vs-Occasional Drinker
5.174800E-01
Daily Drinker-vs-Social Drinker
7.398800E-01
Weekly Drinker-vs-Occasional Drinker
3.553800E-01
Weekly Drinker-vs-Social Drinker
5.227600E-01
Occasional Drinker-vs-Social Drinker
7.104000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.466200E-02
Normal-vs-Grade 2
9.658100E-03
Normal-vs-Grade 3
7.764800E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.874500E-02
Grade 1-vs-Grade 3
3.810100E-02
Grade 1-vs-Grade 4
9.466200E-02
Grade 2-vs-Grade 3
4.721000E-01
Grade 2-vs-Grade 4
9.658100E-03
Grade 3-vs-Grade 4
7.764800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.826800E-01
Normal-vs-NonDiabetic
2.673400E-01
Diabetic-vs-NonDiabetic
9.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.912200E-01
Normal-vs-NoPancreatitis
2.869200E-01
Pancreatitis-vs-NoPancreatitis
4.289400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.966200E-01
Normal-vs-N1
4.374400E-01
N0-vs-N1
1.252980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.837600E-01
Normal-vs-TP53-NonMutant
3.018600E-01
TP53-Mutant-vs-TP53-NonMutant
1.235620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
